-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UNM6tiaswv+8evQ8xOL0g21N9H1V9hhiJBKm5BhHEYcMANpi+IStL1/3mG2NUjNL ekccSxkvwK43BQN9P8kJVQ== 0000950128-97-000527.txt : 19970222 0000950128-97-000527.hdr.sgml : 19970222 ACCESSION NUMBER: 0000950128-97-000527 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970212 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45955 FILM NUMBER: 97527770 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAYER CORP CENTRAL INDEX KEY: 0001008007 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE MELLON BANK CENTER STREET 2: 53RD FLOOR CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 4123945500 MAIL ADDRESS: STREET 1: ONE MELLON BANK CENTRE STREET 2: 53RD FLOOR CITY: PITTSBURGH STATE: PA ZIP: 15219 SC 13G 1 ONYX PHARMACEUTICALS, INC. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* ONYX Pharmaceuticals, Inc. ----------------------------------------- (Name of Issuer) Common Stock, par value $.001 per share ----------------------------------------- (Title of Class of Securities) 683399 10 9 ------------- (CUSIP Number) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages 2 SCHEDULE 13G CUSIP No. 683399 10 9 Page 2 of 5 Pages --------------------- ------------------ (1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Person Bayer Corporation 25-133-9219 --------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of a Group* (a) [ ] (b) [ ] --------------------------------------------------------------------- (3) SEC Use Only --------------------------------------------------------------------- (4) Citizenship or Place of Organization Indiana --------------------------------------------------------------------- (5) Sole Voting Power Number of 945,510 Shares -------------------------------------------------------- Beneficially (6) Shared Voting Power Owned by -0- Each -------------------------------------------------------- Reporting (7) Sole Dispositive Power Person With 945,510 -------------------------------------------------------- (8) Shared Dispositive Power -0- -------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 945,510 --------------------------------------------------------------------- (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares* [ ] (11) Percent of Class Represented by Amount in Row (9) 9.98% --------------------------------------------------------------------- (12) Type of Reporting Person* CO --------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 5 Pages 3 ITEM 1(a). NAME OF ISSUER: ONYX Pharmaceuticals, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 3031 Research Dr. Richmond, CA 94806 ITEM 2(a). NAME OF PERSON FILING: Bayer Corporation ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE: One Mellon Bank Center, 500 Grant Street, 53rd Floor, Pittsburgh, Pennsylvania 15219 ITEM 2(c). CITIZENSHIP: Indiana corporation ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $.001 per share ITEM 2(e). CUSIP NUMBER: 683399 10 9 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13B-1(b), OR 13d-2(d), CHECK WHETHER THE PERSON FILING IS A: Not Applicable ITEM 4. OWNERSHIP: (a) Amount beneficially owned: 945,510 (b) Percent of Class 9.98% Page 3 of 5 Pages 4 (c) Number of Shares as to which such person has: (i) Sole power to vote or direct the vote: 945,510 (ii) Shared power to vote or direct the vote: -0- (iii) Sole power to dispose or to direct the disposition of: 945,510 (iv) Shared power to dispose or to direct the disposition of: -0- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable ITEM 10. CERTIFICATION: Not Applicable Page 4 of 5 Pages 5 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: February 11, 1997 BAYER CORPORATION By: /s/ JON R. WYNE -------------------- Jon R. Wyne Senior Vice President Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----